Silverback Therapeutics
Latest round
- Series C
Last raised
- Sep 2020
Total raised
- $154M
Investors
- 15
About Silverback Therapeutics
Founded in 2016 and based in Washington, US, Silverback Therapeutics, Inc. operates as a biopharmaceutical company that develops tissue-targeted therapeutics to treat patients with cancer, fibrosis, and other infectious diseases.
Who invested in Silverback Therapeutics
15 investors across 3 rounds
See all investors in Silverback Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Silverback Therapeutics
Who invested in Silverback Therapeutics?
Silverback Therapeutics has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Silverback Therapeutics raised?
Silverback Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Silverback Therapeutics last raise money?
Silverback Therapeutics's most recent round on record is a Series C, in Sep 2020.
What does Silverback Therapeutics do?
Founded in 2016 and based in Washington, US, Silverback Therapeutics, Inc.
Where is Silverback Therapeutics headquartered?
Silverback Therapeutics is headquartered in Seattle, US.
Which VCs invest in companies like Silverback Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Silverback Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Silverback Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.